首页> 外文期刊>Memorias do Instituto Oswaldo Cruz >Intradermal Vaccination of Adults with Three Low Doses (2 μg) of Recombinant Hepatitis B Vaccine. II. Persistence of Immunity and Induction of Immunologic Memory
【24h】

Intradermal Vaccination of Adults with Three Low Doses (2 μg) of Recombinant Hepatitis B Vaccine. II. Persistence of Immunity and Induction of Immunologic Memory

机译:成年人的三种低剂量(2μg)重组乙型肝炎疫苗的皮内疫苗接种。二。免疫力的持久性和免疫记忆的诱导

获取原文
       

摘要

Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 μg doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None of the dentists had hepatitis or had received HB vaccine during this period. All subjects were submitted to serological tests for the detection of the following markers of hepatitis B virus (HBV) infection: HBsAg, anti-HBc, HBeAg, anti-HBe, and anti-HBs, with no HBsAg, anti-HBc, HBeAg or anti-HBe being detected. A microparticle enzyme immunoassay (MEIA) revealed the presence of anti-HBs at protective titers (≥ 10 mIU/ml) in 42 dentists (82.4%), with the anti-HBs titer being higher than 100 mIU/ml in 36 of them (70.6%) (good responders), between 10 and 100 mIU/ml in 6 (11.8%) (poor responders), and lower than 10 mIU/ml in 9 (17.6%) (non-responders). According to clinical data and serological tests, none of the dentists had presented disease or latent HBV infection during the eight years following the first vaccination. A 2 μg booster dose was administered intradermally to eight dentists with anti-HBs titers lower than 10 mIU/ml (non-responders) and to six dentists with titers ranging from 10 to 100 mIU/ml (poor responders); the determination of anti-HBs one month later demonstrated the occurrence of seroconversion in the eight non-responders and an increase in anti-HBs titer in the six poor responders. In summary, the present results demonstrated the prolonged persistence of protection against HBV infection and the development of immunologic memory provided by vaccination against HB - with intra-dermal application of three 2 μg doses of the Belgian recombinant vaccine at 0, 1, and 6 months - carried out eight years before in 51 dentists.
机译:在皮内应用三剂2μg比利时乙型肝炎重组疫苗(HB)皮内应用后50天出现血清转换的110名牙医中,在八年之前以第一剂和第二剂之间的间隔一个月和五次施用了在第二和第三剂之间的第一个月中,包括51个用于评估免疫持续性。在此期间,没有牙医感染肝炎或接种过乙肝疫苗。所有受试者均接受血清学检测,以检测以下乙型肝炎病毒(HBV)感染的标志物:HBsAg,抗HBc,HBeAg,抗HBe和抗HBs,无HBsAg,抗HBc,HBeAg或已检测到抗HBe。微粒酶免疫测定法(MEIA)显示42名牙医(82.4%)的保护滴度(≥10 mIU / ml)处存在抗HBs,其中36例中抗HBs滴度高于100 mIU / ml( 70.6%)(良好反应者),6(11.8%)(10.8%)(不良反应者)为10至100 mIU / ml,9(17.6%)(无反应者)低于10 mIU / ml。根据临床数据和血清学测试,在第一次接种后的八年内,没有牙医出现过疾病或潜在的HBV感染。皮内给予抗HBs滴度低于10 mIU / ml的8位牙医皮下注射2μg增强剂量(无反应者),滴定度介于10至100 mIU / ml的6位牙医皮内给予2μg增强剂(反应差者);一个月后测定抗HBs结果表明,在八名无反应者中发生了血清转化,而在六名不良反应者中抗HBs滴度增加。总而言之,本研究结果表明,针对HBV感染的保护作用得以长期持续,并且针对HB疫苗的免疫记忆得到了发展-在0、1、6个月内皮内施用三种2μg比利时重组疫苗-八年前在51位牙医中进行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号